Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory …

CKH Wong, ICH Au, KTK Lau, EHY Lau, BJ Cowling… - MedRxiv, 2022 - medrxiv.org
Background Evidence evaluating real-world effectiveness of oral antivirals against Omicron
variants is lacking. Methods An unselected, territory-wide cohort of all initially non …

[HTML][HTML] Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling …

CK Wong, IC Au, KT Lau, EHY Lau, BJ Cowling… - 2022 - europepmc.org
Methods An unselected, territory-wide cohort of all initially non-hospitalized patients with an
officially registered diagnosis of SARS-CoV-2 infection between 26th February and 3rd May …

[PDF][PDF] Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling …

CKH Wong - scholar.archive.org
Methods An unselected, territory-wide cohort of all initially non-hospitalized patients with an
officially registered diagnosis of SARS-CoV-2 infection between 26th February and 3rd May …